CISAPRIDE IN CHRONIC DYSPEPSIA - RESULTS OF A DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL

被引：24
|
作者：
CHUNG, JM
机构：
[1] Dept. of Internal Medicine, School of Medicine, Kyungbook National University, Taegu
来源：
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY | 1993年 / 28卷
关键词：
CHRONIC DYSPEPSIA; CISAPRIDE;
D O I：
10.3109/00365529309098323
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
The efficacy and tolerability of cisapride in chronic dyspepsia was evaluated in a randomized, double-blind, placebo-controlled study. After 4 weeks' treatment with oral cisapride 10 mg three times daily (n = 14), bloating and epigastric discomfort were significantly reduced compared with placebo (n = 15; p < 0.05). Moreover, the global response to treatment was excellent or good in 71.4% of patients in the cisapride group versus 20.0% with placebo. No significant side effects were observed. It is concluded that cisapride is an effective and well-tolerated treatment for chronic dyspepsia.
引用
收藏
页码：11 / 14
页数：4
相关论文
共 50 条
  • [11] Cisapride in functional dyspepsia in general practice. A placebo-controlled, randomized, double-blind study
    deGroot, GH
    DeBoth, PSM
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1997, 11 (01) : 193 - 199
  • [12] EFFICACY OF CISAPRIDE IN FUNCTIONAL DYSPEPSIA RESISTANT TO DOMPERIDONE OR METOCLOPRAMIDE - A DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    VANOUTRYVE, M
    DENUTTE, N
    VANEEGHEM, P
    GOORIS, JP
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1993, 28 : 47 - 53
  • [13] OBJECTIVE AND SUBJECTIVE RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL USING CISAPRIDE TO TREAT GASTROPARESIS
    RICHARDS, RD
    VALENZUELA, GA
    DAVENPORT, KG
    FISHER, KLK
    MCCALLUM, RW
    DIGESTIVE DISEASES AND SCIENCES, 1993, 38 (05) : 811 - 816
  • [14] Double-Blind, Placebo-Controlled Trial of Famotidine in Children with Abdominal Pain and Dyspepsia
    Mary C. See
    Audrey H. Birnbaum
    Clyde B. Schechter
    Marvin M. Goldenberg
    Keith J. Benkov
    Digestive Diseases and Sciences, 2001, 46 : 985 - 992
  • [15] Rifaximin for the treatment of functional dyspepsia: a double-blind randomized placebo-controlled trial
    Tan, V.
    Liu, K.
    Lam, F.
    Hung, I.
    Yuen, M.
    Leung, W.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2015, 30 : 154 - 154
  • [16] Famotidine in the treatment of functional dyspepsia: a randomized double-blind, placebo-controlled trial
    Amini, Mohsen
    Chehreh, Mohammad Ebrahim Ghamar
    Khedmat, Hossein
    Valizadegan, Ghasem
    Babaei, Marzieh
    Darvishi, Ahmad
    Taheri, Saeed
    JOURNAL OF THE EGYPTIAN PUBLIC HEALTH ASSOCIATION, 2012, 87 (1-2): : 29 - 33
  • [17] ORAL DOMPERIDONE IN CHRONIC POSTPRANDIAL DYSPEPSIA - DOUBLE-BLIND PLACEBO-CONTROLLED EVALUATION
    VANDEMIEROP, L
    RUTGEERTS, L
    VANDENLANGENBERGH, B
    STAESSEN, A
    DIGESTION, 1979, 19 (04) : 244 - 250
  • [18] DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL COMPARING CISAPRIDE AND METOCLOPRAMIDE IN DIABETES WITH AUTONOMIC NEUROPATHY
    DECAESTECKER, JS
    EWING, DJ
    CLARKE, BF
    TOTHILL, P
    HEADING, RC
    DIGESTION, 1986, 34 (02) : 148 - 149
  • [19] EFFECT OF CISAPRIDE IN NONULCER DYSPEPSIA - A PLACEBO-CONTROLLED TRIAL
    AGORASTOS, I
    AKRIVIADIS, E
    GOULIS, G
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1991, 49 (05): : 870 - 877
  • [20] DOMPERIDONE IN THE TREATMENT OF DYSPEPSIA - DOUBLE-BLIND PLACEBO-CONTROLLED STUDY
    ARTS, E
    ANTHONI, H
    DEROY, G
    DHOLLANDER, J
    VERHAEGEN, H
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1979, 7 (02) : 158 - 161
12345